These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14648017)

  • 21. miR-133a enhances the sensitivity of Hep-2 cells and vincristine-resistant Hep-2v cells to cisplatin by downregulating ATP7B expression.
    Wang X; Zhu W; Zhao X; Wang P
    Int J Mol Med; 2016 Jun; 37(6):1636-42. PubMed ID: 27121102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The roles of copper transporters in cisplatin resistance.
    Kuo MT; Chen HH; Song IS; Savaraj N; Ishikawa T
    Cancer Metastasis Rev; 2007 Mar; 26(1):71-83. PubMed ID: 17318448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B.
    Samimi G; Katano K; Holzer AK; Safaei R; Howell SB
    Mol Pharmacol; 2004 Jul; 66(1):25-32. PubMed ID: 15213293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human solid carcinomas.
    Katoh R; Takebayashi Y; Takenoshita S
    Ann Thorac Cardiovasc Surg; 2005 Jun; 11(3):143-5. PubMed ID: 16030471
    [No Abstract]   [Full Text] [Related]  

  • 25. Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin.
    Blair BG; Larson CA; Safaei R; Howell SB
    Clin Cancer Res; 2009 Jul; 15(13):4312-21. PubMed ID: 19509135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic Targeting of ATP7B in Ovarian Carcinoma.
    Mangala LS; Zuzel V; Schmandt R; Leshane ES; Halder JB; Armaiz-Pena GN; Spannuth WA; Tanaka T; Shahzad MM; Lin YG; Nick AM; Danes CG; Lee JW; Jennings NB; Vivas-Mejia PE; Wolf JK; Coleman RL; Siddik ZH; Lopez-Berestein G; Lutsenko S; Sood AK
    Clin Cancer Res; 2009 Jun; 15(11):3770-80. PubMed ID: 19470734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cisplatin efflux, binding and intracellular pH in the HTB56 human lung adenocarcinoma cell line and the E-8/0.7 cisplatin-resistant variant.
    Chau Q; Stewart DJ
    Cancer Chemother Pharmacol; 1999; 44(3):193-202. PubMed ID: 10453720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae.
    Lin X; Okuda T; Holzer A; Howell SB
    Mol Pharmacol; 2002 Nov; 62(5):1154-9. PubMed ID: 12391279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copper transporter 2 regulates intracellular copper and sensitivity to cisplatin.
    Huang CP; Fofana M; Chan J; Chang CJ; Howell SB
    Metallomics; 2014 Mar; 6(3):654-61. PubMed ID: 24522273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitization of cancer cells towards Cisplatin and Carboplatin by protein kinase D inhibitors through modulation of ATP7A/B (copper transport ATPases).
    Janardhanan P; Somasundaran AK; Balakrishnan AJ; Pilankatta R
    Cancer Treat Res Commun; 2022; 32():100613. PubMed ID: 35908410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of copper transporters in the uptake and efflux of platinum containing drugs.
    Safaei R
    Cancer Lett; 2006 Mar; 234(1):34-9. PubMed ID: 16297532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.
    Wang W; Ke S; Chen G; Gao Q; Wu S; Wang S; Zhou J; Yang X; Lu Y; Ma D
    Oncol Rep; 2004 Dec; 12(6):1365-70. PubMed ID: 15547764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of copper transporter 2 expression by copper and cisplatin in human ovarian carcinoma cells.
    Blair BG; Larson CA; Adams PL; Abada PB; Safaei R; Howell SB
    Mol Pharmacol; 2010 Jun; 77(6):912-21. PubMed ID: 20194531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual role of LRRC8A-containing transporters on cisplatin resistance in human ovarian cancer cells.
    Sørensen BH; Dam CS; Stürup S; Lambert IH
    J Inorg Biochem; 2016 Jul; 160():287-95. PubMed ID: 27112899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The CXXC motifs in the metal binding domains are required for ATP7B to mediate resistance to cisplatin.
    Safaei R; Adams PL; Maktabi MH; Mathews RA; Howell SB
    J Inorg Biochem; 2012 May; 110():8-17. PubMed ID: 22459168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Copper-transporting P-type ATPase, ATP7A, confers multidrug resistance and its expression is related to resistance to SN-38 in clinical colon cancer.
    Owatari S; Akune S; Komatsu M; Ikeda R; Firth SD; Che XF; Yamamoto M; Tsujikawa K; Kitazono M; Ishizawa T; Takeuchi T; Aikou T; Mercer JF; Akiyama S; Furukawa T
    Cancer Res; 2007 May; 67(10):4860-8. PubMed ID: 17510416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of copper transporters in resistance to platinating agents.
    Rabik CA; Maryon EB; Kasza K; Shafer JT; Bartnik CM; Dolan ME
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):133-42. PubMed ID: 18998134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Copper transporters and chaperones CTR1, CTR2, ATOX1, and CCS as determinants of cisplatin sensitivity.
    Bompiani KM; Tsai CY; Achatz FP; Liebig JK; Howell SB
    Metallomics; 2016 Sep; 8(9):951-62. PubMed ID: 27157188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W; Chaney SG
    Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Collateral sensitivity to cisplatin in KB-8-5-11 drug-resistant cancer cells.
    Doherty B; Lawlor D; Gillet JP; Gottesman M; O'Leary JJ; Stordal B
    Anticancer Res; 2014 Jan; 34(1):503-7. PubMed ID: 24403508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.